O

OrbusNeich Medical Group Holdings Ltd
HKEX:6929

Watchlist Manager
OrbusNeich Medical Group Holdings Ltd
HKEX:6929
Watchlist
Price: 4.1 HKD -1.68% Market Closed
Market Cap: 3.4B HKD
Have any thoughts about
OrbusNeich Medical Group Holdings Ltd?
Write Note

OrbusNeich Medical Group Holdings Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

OrbusNeich Medical Group Holdings Ltd
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
O
OrbusNeich Medical Group Holdings Ltd
HKEX:6929
Cash from Financing Activities
$884k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Huakang Biomedical Holdings Co Ltd
HKEX:8622
Cash from Financing Activities
ÂĄ1m
CAGR 3-Years
N/A
CAGR 5-Years
-51%
CAGR 10-Years
N/A
K
Kaisa Health Group Holdings Ltd
HKEX:876
Cash from Financing Activities
-HK$8.8m
CAGR 3-Years
34%
CAGR 5-Years
14%
CAGR 10-Years
18%
K
Kelfred Holdings Ltd
HKEX:1134
Cash from Financing Activities
-HK$4.2m
CAGR 3-Years
44%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Arts Optical International Holdings Ltd
HKEX:1120
Cash from Financing Activities
HK$25m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

OrbusNeich Medical Group Holdings Ltd
Glance View

Market Cap
3.4B HKD
Industry
Health Care

OrbusNeich Medical Group Holdings Ltd. operates as an investment holding company. The company employs 880 full-time employees The company went IPO on 2022-12-23. The firm is engaged in the design, development, manufacture, distribution and sale of interventional medical devices for the treatment of coronary heart disease and peripheral vascular diseases. The firm's main products include percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) balloons. In addition, the Company's products also include semi-compliant balloons and scoring balloons for pre-dilatation and lesion preparation, coronary stents for implantation, non-compliant balloons for post-dilatation and specialty catheters. The firm mainly conducts its businesses in domestic and overseas markets.

Intrinsic Value
4.36 HKD
Undervaluation 6%
Intrinsic Value
Price
O

See Also

What is OrbusNeich Medical Group Holdings Ltd's Cash from Financing Activities?
Cash from Financing Activities
884k USD

Based on the financial report for Dec 31, 2023, OrbusNeich Medical Group Holdings Ltd's Cash from Financing Activities amounts to 884k USD.

What is OrbusNeich Medical Group Holdings Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 1Y
-98%

Over the last year, the Cash from Financing Activities growth was -98%.

Back to Top